1.Finite element analysis of simulated treatment of Sanders type Ⅲcalcaneal fractures with sustentacular screw placement of sustentaculum tali
Guang-Sheng TANG ; Qi WANG ; Yao XU ; Bing WANG ; Jian-Ning SUN ; De-Guang WANG
Acta Anatomica Sinica 2025;56(3):315-322
Objective To construct a finite element analysis model for the treatment of calcaneal fracture for Sanders Ⅲ type calcaneal by using simulated sustentaculum tali sustentacular screw placement,and to explore the effectiveness of the treatment of Sanders typeⅢcalcaneal fracture.Methods The finite element analysis method was used to study the effectiveness of the treatment of Sanders Ⅲ calcaneal fracture.Three calcaneal specimens of a healthy adult were taken for Micro-CT scanning to obtain the CT sections data,then Mimics 21.0 and Geomagic Wrap 2017 software were used to reconstruct the three-dimensional model of normal calcaneal bone,and SolidWorks 2017 software was used to map the internal fixation and fracture model according to the clinical fracture cases,and simulated surgery was performed.The data obtained were imported into ANSYS 17.0 finite element analysis software for material assignment and mesh division to establish a three-dimensional finite element model.The load and boundary constraints were applied to each model to perform finite element analysis and calculation,and then the stress of the finite element model and the maximum displacement of the fracture end were extracted.Results The maximum stress of the overall structure of each model was concentrated on internal fixation,in which the maximum stress of sustentaculum tali fracture and the maximum stress of screws in all fracture models are located on the sustentaculum tali sustentacular screw.The displacement of fracture end in each finite element model was less than 0.15 mm,and no internal fixation failure occurred.Conclusion It is effective to simulate the treatment of calcaneal fracture of Sanders type Ⅲ by using of sustentaculum tali sustentacular screw.
2.Comparison of Therapeutic Efficacy between Hypomenthylating Agents Combined with Venetoclax and Half Dose Priming Regimen in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia.
Ming-Zhu XU ; Man QIAO ; Ai-Ning SUN ; De-Pei WU ; Sheng-Li XUE ; Hai-Xia ZHOU
Journal of Experimental Hematology 2022;30(6):1631-1636
OBJECTIVE:
To compare the clinical efficacy and safety of hypomenthylating agents (HMA) combined with Venetoclax (VEN) and half dose priming regimen (CAG-like) in the treatment of elderly patients with newly diagnosed acute myeloid leukemia (AML) who were not suitable for intensive chemotherapy.
METHODS:
The clinical data of 43 newly diagnosed elderly patients with AML who were not suitable for intensive chemotherapy in our hospital from April 2019 to October 2020 were retrospectively analyzed. Among them, 16 cases received HMA-VEN regimen and 27 cases received HMA-CAG-like regimen. The remission rate, early mortality and survival were compared between the two groups. And, the patients were grouped according to HCT-CI score. The effects of two different regimens in different groups on the efficacy and survival of patients were compared, and the prognosis of patients was further analyzed.
RESULTS:
After one course of treatment, the total remission rate of HMA-VEN group and HMA-CAG-like group was 81.3% (13/16) and 51.9% (14/27), respectively, and the difference between the two groups was statistically significant (χ2=4.650, P=0.045). The median overall survival (OS) time of HMA-VEN group had not yet reached, while that of HMA-CAG-like group was 11.2 months, and the HMA-VEN group had a longer OS (P=0.055). There was no tumor lysis syndrome occurred in both groups. The main adverse reactions were digestive tract reaction, bone marrow suppression and infection. The amount of agranulocytosis infection, pulmonary infection and platelet infusion in HMA-VEN group were significantly lower than those in HMA-CAG-like group (P<0.05), while the time of agranulocytosis and amount of erythrocyte infusion were similar (P>0.05). In HMA-Ven group 1 case died early, while in HMA-CAG-like group 8 cases died early due to pulmonary infection, respiratory failure, cerebral hemorrhage, and alveolar hemorrhage, the mortality in HMA-CAG-like group was significantly higher than that in HMA-VEN group (P=0.043). Among 43 patients, there was a significant difference in OS between HCT score 0-2 group and ≥3 group (P=0.033). In HMA-CAG-like group, patients with HCT score ≥3 had a worse prognosis (P=0.01), while in HMA-VEN group patients showed no statistically significant difference in prognosis (P=0.681). In HCT score 0-2 group, 9 cases receiving HMA-VEN regimen and 22 cases receiving HMA-CAG-like regimen showed no statistical difference in OS (P=0.281). In HCT score ≥3 group, 7 cases receiving HMA-VEN regimen had a longer OS than 5 cases receiving HMA-CAG-like regimen (P=0.015).
CONCLUSION
Venetoclax combined with HMA can achieve higher response rate, lower early mortality, and longer OS, especially in those with more comorbidities and poor tolerability.
Humans
;
Aged
;
Retrospective Studies
;
Leukemia, Myeloid, Acute/drug therapy*
3.A comparison of CAS risk model and CHA2DS2-VASc risk model in guiding anticoagulation treatment in Chinese patients with non-valvular atrial fibrillation.
Jia Long DENG ; Liu HE ; Chao JIANG ; Yi Wei LAI ; De Yong LONG ; Cai Hua SANG ; Chang Qi JIA ; Li FENG ; Xu LI ; Man NING ; Rong HU ; Jian Zeng DONG ; Xin DU ; Ri Bo TANG ; Chang Sheng MA
Chinese Journal of Cardiology 2022;50(9):888-894
Objective: To compare the differences between CAS risk model and CHA2DS2-VASc risk score in predicting all cause death, thromboembolic events, major bleeding events and composite endpoint in patients with nonvalvular atrial fibrillation. Methods: This is a retrospective cohort study. From the China Atrial Fibrillation Registry cohort study, the patients with atrial fibrillation who were>18 years old were randomly divided into CAS risk score group and CHA2DS2-VASc risk score group respectively. According to the anticoagulant status at baseline and follow-up, patients in the 2 groups who complied with the scoring specifications for anticoagulation were selected for inclusion in this study. Baseline information such as age and gender in the two groups were collected and compared. Follow-up was performed periodically to collect information on anticoagulant therapy and endpoints. The endpoints were all-cause death, thromboembolism events and major bleeding, the composite endpoint events were all-cause death and thromboembolism events. The incidence of endpoints in CAS group and CHA2DS2-VASc group was analyzed, and multivariate Cox proportional risk model was used to analyze whether the incidence of the endpoints was statistically different between the two groups. Results: A total of 5 206 patients with AF were enrolled, average aged (63.6±12.2) years, and 2092 (40.2%) women. There were 2 447 cases (47.0%) in CAS risk score group and 2 759 cases (53.0%) in CHA2DS2-VASc risk score group. In the clinical baseline data of the two groups, the proportion of left ventricular ejection fraction<55%, non-paroxysmal atrial fibrillation, oral warfarin and HAS BLED score in the CAS group were lower than those in the CHA2DS2-VASc group, while the proportion of previous diabetes history and history of antiplatelet drugs in the CAS group was higher than that in the CHA2DS2-VASc group, and there was no statistical difference in other baseline data. Patients were followed up for (82.8±40.8) months. In CAS risk score group, 225(9.2%) had all-cause death, 186 (7.6%) had thromboembolic events, 81(3.3%) had major bleeding, and 368 (15.0%) had composite endpoint. In CHA2DS2-VASc risk score group, 261(9.5%) had all-cause death 209(7.6%) had thromboembolic events, 112(4.1%) had major bleeding, and 424 (15.4%) had composite endpoint. There were no significant differences in the occurrence of all-cause death, thromboembolic events, major bleeding and composite endpoint between anticoagulation in CAS risk score group and anticoagulation in CHA2DS2-VASc risk score group (log-rank P =0.643, 0.904, 0.126, 0.599, respectively). Compared with CAS risk score, multivariable Cox proportional hazards regression models showed no significant differences for all-cause death, thromboembolic events, major bleeding and composite endpoint between the two groups with HR(95%CI) 0.95(0.80-1.14), 1.00(0.82-1.22), 0.83(0.62-1.10), 0.96(0.84-1.11), respectively. All P>0.05. Conclusions: There were no significant differences between CAS risk model and CHA2DS2-VASc risk score in predicting all-cause death, thromboembolic events, and major bleeding events in Chinese patients with non-valvular atrial fibrillation.
Adolescent
;
Anticoagulants
;
Atrial Fibrillation/drug therapy*
;
Cohort Studies
;
Female
;
Hemorrhage/complications*
;
Humans
;
Male
;
Retrospective Studies
;
Risk Assessment
;
Stroke/epidemiology*
;
Stroke Volume
;
Thromboembolism/etiology*
;
Ventricular Function, Left
4.The Combined Effect of Dyslipidemia on the Incidence of Type 2 Diabetes: A Prospective Cohort Study in Northwest of China.
Min Zhen WANG ; Tian DAI ; Shan ZHENG ; Cheng YU ; Miao XIA ; Hong Yan YANG ; De Sheng ZHANG ; Chun YIN ; Ya Fei JIN ; Ning CHENG ; Ya Na BAI
Biomedical and Environmental Sciences 2021;34(10):814-818
5.Sex-specific and Dose-response Relationship between the Incidence of Gallstones and Components of the Metabolic Syndrome in Jinchang Cohort: A Prospective Study.
Jing Li YANG ; Jun Jun HUANG ; Ning CHENG ; De Sheng ZHANG ; Si Min LIU ; Wen Ya HUANG ; Na LI ; Pei Yao HUANG ; Jiao DING ; Nian LIU ; Kai Fang BAO ; Jie DING ; Xiao Liang CHEN ; Tong Zhang ZHENG ; Ya Na BAI
Biomedical and Environmental Sciences 2020;33(8):633-638
6.Immunosuppression medication and cardiac function improvement treatments might prevent Takayasu arteritis patients with aortitis from receiving cardiac surgery.
Xiao-Min DAI ; Yu-Jiao WANG ; Zhen-Chun ZHANG ; Cheng-De YANG ; Rui WU ; Zhen-Yuan ZHOU ; Xiao-Xiang CHEN ; Xiao-Ning SUN ; Chun-Sheng WANG ; Li-Li MA ; Lin-Di JIANG
Chinese Medical Journal 2020;134(5):625-627
7.Proteomics Study on the Differentially Expressed Proteins in c-fos-silenced Cells Exposed to PM2.5
Ying CAI ; Kai ZHENG ; Bing Run LI ; Yuan Shu YU ; Ning LIU ; Jia Jia JI ; Chen YANG ; Sheng De WU ; Jian Shuang QIN ; Ru Bo LI ; Hui Zhao ZHANG ; Yun Xin XU
Biomedical and Environmental Sciences 2020;33(9):680-689
Objective To investigate the effect of c-fos gene silencing on differentially expressed proteins (DEPs) in human bronchial epithelial (HBE) cells after exposure to fine particulate matter (PM2.5).Methods HBE cells and c-fos-silenced HBE cells were exposed to 50 μg/mL PM2.5, LC-MS/MS and tandem mass tag (TMT) labeling methods were combined with bioinformatics methods, and DEPs and interaction networks were identified.Results In the HBE group, 414 DEPs were screened, of which 227 were up-regulated and 187 down-regulated. In the c-fos silenced HBE group, 480 DEPs were screened, including 240 up-regulated proteins and 240 down-regulated proteins. KEGG annotations showed that DEPs in the HBE group are mainly concentrated in the glycolysis/gluconeogenesis pathway and those in the c-fos silenced group are concentrated mainly in endoplasmic reticulum and the processing of proteins. Additionally, the abnormal expression of GPRC5C, DKK4, and UBE2C was identified in top 15 DEPs. After constructing the protein interaction network, 20 Hub proteins including HNRNPA2B1, HNRNPL, RPS15A, and RPS25 were screened from the HBE group and the c-fos silenced HBE group.Conclusion c-fos gene affected the expression of cancer-related proteins. Our results provided a scientific basis for further study of PM2.5-induced carcinogenesis mechanism.
8.Occupational exposure to heavy metals, alcohol intake, and risk of type 2 diabetes and prediabetes among Chinese male workers
Yang AI-MIN ; Hu XIAO-BIN ; Liu SIMIN ; Cheng NING ; Zhang DE-SHENG ; Li JUAN-SHENG ; Li HAI-YAN ; Ren XIAO-WEI ; Li NA ; Sheng XI-PIN ; Ding JIAO ; Zheng SHAN ; Wang MIN-ZHENG ; Zheng TONG-ZHANG ; Bai YA-NA
Chronic Diseases and Translational Medicine 2019;5(2):97-104
Objective:Both exposure to heavy metals and alcohol intake have been related to the risk of type 2 diabetes (T2D).In this study,we aimed to assess the potential interactions between metal exposure and alcohol intake on the risk of T2D and prediabetes in a cohort of Chinese male workers.Methods:We conducted a cross-sectional analysis of 26,008 Chinese male workers in an occupational cohort study from 2011 to 2013.We assessed metal exposure and alcohol consumption at baseline in these workers who were aged ≥20 years.Based on occupations which were categorized according to measured urine metal levels,multiple logistic regression analyses were used to evaluate the independent and joint effects of metal and alcohol exposure on the risk of T2D and prediabetes.Results:Risks of T2D (Ptrend =0.001) and prediabetes (Ptrend =0.001) were significantly elevated with increasing number of standard drinks per week,years of drinking,and lifetime alcohol consumption.An adjusted odds ratio (OR) of 6.1 (95% confidence interval [CI]:4.8-7.8) was observed for the smelting/refining workers (highest metal exposure levels) who had the highest lifetime alcohol consumption (>873 kg) (Pinteraction =0.018),whereas no statistically significant joint effect was found for prediabetes (Pinteraction =0.515).Conclusions:Both exposures to metal and heavy alcohol intake were associated with the risk of diabetes in this large cohort of male workers.There was a strong interaction between these two exposures in affecting diabetes risk that needs to be confirmed in future studies.
9.Occupational exposure to heavy metals, alcohol intake, and risk of type 2 diabetes and prediabetes among Chinese male workers
Yang AI-MIN ; Hu XIAO-BIN ; Liu SIMIN ; Cheng NING ; Zhang DE-SHENG ; Li JUAN-SHENG ; Li HAI-YAN ; Ren XIAO-WEI ; Li NA ; Sheng XI-PIN ; Ding JIAO ; Zheng SHAN ; Wang MIN-ZHENG ; Zheng TONG-ZHANG ; Bai YA-NA
Chronic Diseases and Translational Medicine 2019;5(2):97-104
Objective:Both exposure to heavy metals and alcohol intake have been related to the risk of type 2 diabetes (T2D).In this study,we aimed to assess the potential interactions between metal exposure and alcohol intake on the risk of T2D and prediabetes in a cohort of Chinese male workers.Methods:We conducted a cross-sectional analysis of 26,008 Chinese male workers in an occupational cohort study from 2011 to 2013.We assessed metal exposure and alcohol consumption at baseline in these workers who were aged ≥20 years.Based on occupations which were categorized according to measured urine metal levels,multiple logistic regression analyses were used to evaluate the independent and joint effects of metal and alcohol exposure on the risk of T2D and prediabetes.Results:Risks of T2D (Ptrend =0.001) and prediabetes (Ptrend =0.001) were significantly elevated with increasing number of standard drinks per week,years of drinking,and lifetime alcohol consumption.An adjusted odds ratio (OR) of 6.1 (95% confidence interval [CI]:4.8-7.8) was observed for the smelting/refining workers (highest metal exposure levels) who had the highest lifetime alcohol consumption (>873 kg) (Pinteraction =0.018),whereas no statistically significant joint effect was found for prediabetes (Pinteraction =0.515).Conclusions:Both exposures to metal and heavy alcohol intake were associated with the risk of diabetes in this large cohort of male workers.There was a strong interaction between these two exposures in affecting diabetes risk that needs to be confirmed in future studies.
10. A new norclerodan diterpene from twigs and leaves of Croton euryphyllus
Chinese Traditional and Herbal Drugs 2018;49(23):5499-5502
To study the diterpenoids from the twigs and leaves of Croton euryphyllus. Methods Compounds were isolated and purified by column chromatography on silica gel, MCI, and semi-preparative HPLC, and their structures were elucidated by spectroscopic analysis and comparisons with published literature values. Results Four compounds were obtained from the petroleum ether fraction of 95% alcoholic extract of the twigs and leaves of C. euryphyllus, and structures were identified as crotoeurin D (1), mallotucin C (2), mallotucin D (3), and plaunotol (4), respectively. Conclusion Compound 1 is a new norclerodan diterpene. Compounds 2-4 are isolated from this plant for the first time.

Result Analysis
Print
Save
E-mail